高级检索
当前位置: 首页 > 详情页

Clinical characteristics and risk factors for readmission after deep anterior lamellar keratoplasty: a nationwide, cross-sectional, multicenter study

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Wenzhou Med Univ, Eye Hosp, Natl Clin Res Ctr Ocular Dis, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China [2]Wenzhou Med Univ, Ningbo Eye Hosp, Ningbo Eye Inst, Dept Ophthalmol, Ningbo, Zhejiang, Peoples R China [3]Xian 1 Hosp, Dept Ophthalmol, 30 Fen Alley,South St, Xian, Shaanxi, Peoples R China [4]Taizhou Municipal Hosp, Ctr Ophthalmol, Taizhou, Zhejiang, Peoples R China [5]Chongqing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Chongqing, Peoples R China [6]Cent South Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China [7]Third Peoples Hosp Dalian, Dept Ophthalmol, Dalian, Liaoning, Peoples R China [8]Dalian Municipal Eye Hosp, Dalian, Liaoning, Peoples R China [9]Shanxi Eye Hosp, Dept Cornea, Taiyuan, Shanxi, Peoples R China [10]Yunnan Univ, Peoples Hosp Yunnan Prov 2, Affiliated Hosp, Dept Ophthalmol, Kunming, Yunnan, Peoples R China [11]Nanchang Univ, Affiliated Eye Hosp, Jiangxi Med Coll, Natl Clin Res Ctr Ocular Dis,Dept Ophthalmol,Jiang, Nanchang, Jiangxi, Peoples R China [12]Nanjing Med Univ, Affiliated Eye Hosp, Dept Ophthalmol, Nanjing, Jiangsu, Peoples R China [13]Tianjin Med Univ Eye Hosp, Eye Inst, Natl Clin Res Ctr Ocular Dis, Sch Optometry,Corneal & Refract Surg Ctr,Tianjin B, Tianjin, Peoples R China [14]Fujian Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Fuzhou, Fujian, Peoples R China [15]Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Dept Ophthalmol, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China [16]Wuhan Univ, Dept Ophthalmol, Renmin Hosp, Wuhan, Hubei, Peoples R China [17]Ningxia Med Univ, Ningxia Eye Hosp, Peoples Hosp Ningxia Hui Autonomous Reg, Clin Med Coll 3,Dept Ophthalmol, Yinchuan, Ningxia Hui Aut, Peoples R China [18]Lanzhou Univ Second Hosp, Dept Ophthalmol, Lanzhou, Gansu, Peoples R China [19]First Peoples Hosp Aksu, Aksu, Xinjiang, Peoples R China
出处:
ISSN:

关键词: Deep anterior lamellar keratoplasty Unplanned readmission Risk factors

摘要:
BackgroundTo assess the incidence, cause and risk factors for unplanned readmission within 90 days after deep anterior lamellar keratoplasty (DALK).MethodsA multicentre cross-sectional study of 3603 eyes of 3588 patients after keratoplasty between January 1st, 2019, and September 30th, 2021 in 16 hospitals across China was performed. The demographic and clinical features between patients after DALK with 90-day unplanned readmission and those who did not have been compared. The risk factors of unplanned readmission were identified by a multivariable Cox regression model.ResultsAmong 873 patients (878 eyes) after DALK, and the primary indications for DALK were keratitis (391 eyes, 44.53%) and keratoconus (275 eyes, 31.32%). The rates of unplanned readmission within 30 days, 60 days, and 90 days were 1.95%, 4.01%, and 5.15%. The main reason of 90-day readmission was infectious keratitis (18 eyes, 40.00%), followed by corneal epithelial defects (11 eyes, 24.44%) and immune-related keratitis (10 eyes, 22.22%). Patients readmitted within 90 days exhibit a more advanced age (p = 0.013). It is also more concentrated in patients with corneal ulcers or perforations (p = 0.029) or blindness (p = 0.02). Compared with patients with keratoconus, patients with keratitis (HR = 3.545, 95% CI 1.104-11.386, p = 0.034) and corneal degeneration or malnutrition (HR = 6.470, 95% CI 1.942-21.560, p = 0.002) are more likely to have an unplanned readmission risk within 90 days.ConclusionThe main causes of unplanned readmission within 90 days after DALK were infectious keratitis, corneal epithelial defects, and immune-related keratitis. The indications for DALK were associated with 90-day readmissions.Clinical trial numberNot applicable.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 眼科学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q3 OPHTHALMOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Wenzhou Med Univ, Eye Hosp, Natl Clin Res Ctr Ocular Dis, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China [4]Taizhou Municipal Hosp, Ctr Ophthalmol, Taizhou, Zhejiang, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Wenzhou Med Univ, Eye Hosp, Natl Clin Res Ctr Ocular Dis, Dept Ophthalmol, Wenzhou, Zhejiang, Peoples R China [2]Wenzhou Med Univ, Ningbo Eye Hosp, Ningbo Eye Inst, Dept Ophthalmol, Ningbo, Zhejiang, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:89078 今日访问量:0 总访问量:752 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号 ICP备案:滇ICP备15003244号